| Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide SR McCurdy, JA Kanakry, MM Showel, HL Tsai, J Bolaños-Meade, ... Blood, The Journal of the American Society of Hematology 125 (19), 3024-3031, 2015 | 312 | 2015 |
| Adoptive T cell immunotherapy for cancer K Perica, JC Varela, M Oelke, J Schneck Rambam Maimonides medical journal 6 (1), 2015 | 290 | 2015 |
| Clinical implications of T cell exhaustion for cancer immunotherapy A Chow, K Perica, CA Klebanoff, JD Wolchok Nature reviews Clinical oncology 19 (12), 775-790, 2022 | 267 | 2022 |
| Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults YL Kasamon, J Bolaños-Meade, GT Prince, HL Tsai, SR McCurdy, ... Journal of Clinical Oncology 33 (28), 3152-3161, 2015 | 251 | 2015 |
| Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells JC Sunshine, K Perica, JP Schneck, JJ Green Biomaterials 35 (1), 269-277, 2014 | 249 | 2014 |
| Magnetic field-induced T cell receptor clustering by nanoparticles enhances T cell activation and stimulates antitumor activity K Perica, A Tu, A Richter, JG Bieler, M Edidin, JP Schneck ACS nano 8 (3), 2252-2260, 2014 | 232 | 2014 |
| Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activation RA Meyer, JC Sunshine, K Perica, AK Kosmides, K Aje, JP Schneck, ... Small (Weinheim an der Bergstrasse, Germany) 11 (13), 1519, 2015 | 185 | 2015 |
| Nanoscale artificial antigen presenting cells for T cell immunotherapy K Perica, ADL Medero, M Durai, YL Chiu, JG Bieler, L Sibener, ... Nanomedicine: Nanotechnology, Biology and Medicine 10 (1), 119-129, 2014 | 159 | 2014 |
| Enrichment and expansion with nanoscale artificial antigen presenting cells for adoptive immunotherapy K Perica, JG Bieler, C Schutz, JC Varela, J Douglass, A Skora, YL Chiu, ... ACS nano 9 (7), 6861-6871, 2015 | 145 | 2015 |
| The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles RM Samstein, K Perica, F Balderrama, M Look, TM Fahmy Biomaterials 29 (6), 703-708, 2008 | 103 | 2008 |
| Building a CAR garage: preparing for the delivery of commercial CAR T cell products at Memorial Sloan Kettering Cancer Center K Perica, KJ Curran, RJ Brentjens, SA Giralt Biology of Blood and Marrow Transplantation 24 (6), 1135-1141, 2018 | 90 | 2018 |
| Linking form to function: Biophysical aspects of artificial antigen presenting cell design K Perica, AK Kosmides, JP Schneck Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1853 (4), 781-790, 2015 | 52 | 2015 |
| Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cells C Schütz, JC Varela, K Perica, C Haupt, M Oelke, JP Schneck Oncotarget 7 (42), 68503, 2016 | 33 | 2016 |
| Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia K Perica, J Flynn, KJ Curran, I Rivere, X Wang, B Senechal, E Halton, ... Leukemia 35 (11), 3268-3271, 2021 | 24 | 2021 |
| Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult ALL. K Perica, J Flynn, KJ Curran, X Wang, E Halton, C Diamonte, J Pineda, ... Journal of Clinical Oncology 37 (15_suppl), 2520-2520, 2019 | 13 | 2019 |
| Modulation of MHC binding by lateral association of TCR and coreceptor K Perica, JG Bieler, M Edidin, J Schneck Biophysical journal 103 (9), 1890-1898, 2012 | 12 | 2012 |
| Dawn of chimeric antigen receptor T cell therapy in non‐Hodgkin Lymphoma K Perica, ML Palomba, RJ Brentjens Advances in cell and gene therapy 1 (3), e23, 2018 | 3 | 2018 |
| Immunoengineering: Biodegradable Nanoellipsoidal Artificial Antigen Presenting Cells for Antigen Specific T‐Cell Activation (Small 13/2015) RA Meyer, JC Sunshine, K Perica, AK Kosmides, K Aje, JP Schneck, ... Small 11 (13), 1612-1612, 2015 | 3 | 2015 |
| Peri-car T-cell management K Perica, KJ Curran, JH Park Chimeric Antigen Receptor T-Cell Therapies for Cancer, 29-44, 2020 | 2 | 2020 |
| Enrichment and Expansion of Mart-1, NY-ESO and WT1 Specifc CD8+ T Cells Using Nano-Particle Artificial Antigen Presenting Cells (Nano-aAPCs) JC Varela, K Perica, C Schuetz, J Bieler, C Haupt, M Oelke, J Schneck Blood 124 (21), 2443, 2014 | | 2014 |
Jonathan P SchneckProfessor of Pathology, Johns Hopkins School of Medicine在 jhmi.edu 的电子邮件经过验证
